person · Reporting owner

OCONNELL MAUREEN

Disclosed activity across 6 companies

Tapewire entity: 9993
SEC CIK: 0001111318

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
ACACIA RESEARCH CORPACTG · Entity 5559	Director	September 02, 2026	September 04, 2026
HARTE HANKS INCHRTH · Entity 7438	Director	March 21, 2020	September 02, 2020
SCHOLASTIC CORPSCHL · Entity 5192	EVP, CAO & CFO	September 25, 2017	September 26, 2017
TEREX CORPTEX · Entity 3718	Director	June 26, 2026	June 30, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ACACIA RESEARCH CORP

Report date September 02, 2026 · Filed September 04, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
ACTG Common StockSEC Table I · non-derivative	Direct	254,655	Ending reported balance After 2026-09-03 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2026-09-02 · Sale · Disposed 20,534 · Balance 267,121 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.615 to $4.645, inclusive. The Reporting Person undertakes to provide to Acacia Research Corporation ("Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form. Row 2 · 2026-09-03 · Sale · Disposed 12,466 · Balance 254,655 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.51 to $4.66, inclusive. The Reporting Person undertakes to provide to Acacia Research Corporation ("Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.615 to $4.645, inclusive. The Reporting Person undertakes to provide to Acacia Research Corporation ("Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.51 to $4.66, inclusive. The Reporting Person undertakes to provide to Acacia Research Corporation ("Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form.

HARTE HANKS INC

Report date March 21, 2020 · Filed September 02, 2020

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	29,971	Ending reported balance After 2020-07-22 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2020-03-21 · Exercise / conversion · Acquired 23,136 · Balance 25,414 F1: Restricted stock units ("RSU") convert into common stock on a one-for-one basis. Row 2 · 2020-07-22 · Exercise / conversion · Acquired 4,557 · Balance 29,971 F1: Restricted stock units ("RSU") convert into common stock on a one-for-one basis.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2020-03-21 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2020-03-21 · Exercise / conversion · Disposed 23,136 · Balance 0 F1: Restricted stock units ("RSU") convert into common stock on a one-for-one basis. F2: On March 21 2019, the reporting person was granted 23,136 RSUs, which vest after one full year from the grant date.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2020-07-22 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2020-07-22 · Exercise / conversion · Disposed 4,557 · Balance 0 F1: Restricted stock units ("RSU") convert into common stock on a one-for-one basis. F3: On July 27, 2018, the reporting person was granted 6,835 RSUs, vesting in three equal annual installments beginning on the first anniversary of the grant date. We accelerated the vesting of this award in connection with the reporting person's departure from the Board.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock units ("RSU") convert into common stock on a one-for-one basis.

F2: On March 21 2019, the reporting person was granted 23,136 RSUs, which vest after one full year from the grant date.

F3: On July 27, 2018, the reporting person was granted 6,835 RSUs, vesting in three equal annual installments beginning on the first anniversary of the grant date. We accelerated the vesting of this award in connection with the reporting person's departure from the Board.

SCHOLASTIC CORP

Report date September 25, 2017 · Filed September 26, 2017

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	31,121	Reported balance After 2017-09-25 transaction · row 1 1 source row Row 1 · 2017-09-25 · Tax withholding · Disposed 800 · Balance 31,121 F1: Represents shares withheld to cover taxes owed upon the vesting of 1,550 restricted stock units.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares withheld to cover taxes owed upon the vesting of 1,550 restricted stock units.

TEREX CORP

Report date June 26, 2026 · Filed June 30, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, $ .01 par valueSEC Table I · non-derivative	Direct	18,235	Reported balance After 2026-06-26 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2026-06-26 · Grant · Acquired 1,880 · Balance 18,235 F1: Represents shares purchased under the Company's Deferred Compensation Plan representing partial payment of annual director retainer. F2: Total includes previously reported restricted stock units. F3: Ownership includes shares received as a dividend.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares purchased under the Company's Deferred Compensation Plan representing partial payment of annual director retainer.

F2: Total includes previously reported restricted stock units.

F3: Ownership includes shares received as a dividend.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

REV Group, Inc.

Report date February 02, 2026 · Filed February 03, 2026

Section 16 reporting ended · disclosed 2026-02-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Last balance in matching sequence After 2026-02-02 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2026-02-02 · Disposition to issuer · Disposed 13,434 · Balance 2,105 F1: On February 2, 2026, pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of October 29, 2025, by and among Terex Corporation, a Delaware corporation ("Terex"), Tag Merger Sub 1 Inc. ("Merger Sub 1"), a Delaware corporation and wholly owned subsidiary of Terex, Tag Merger Sub 2 LLC, a Delaware limited liability company and wholly owned subsidiary of Terex ("Merger Sub 2"), and REV Group, Inc. (the "Issuer"), among other things, Merger Sub 1 merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Terex (the "First Merger"). Immediately following the First Merger, Issuer merged with and into Merger Sub 2, with Merger Sub 2 continuing as the surviving corporation and a wholly owned subsidiary of Terex. F2: At the effective time of the First Merger (the "Effective Time"), each outstanding share of Issuer common stock ("Issuer Common Stock") held by the reporting person as of immediately prior to the Effective Time was cancelled and converted into the right to receive from Terex (i) 0.9809 shares of Terex common stock, par value $0.01 per share ("Terex Common Stock") and (ii) $8.71 in cash without interest. Row 2 · 2026-02-02 · Disposition to issuer · Disposed 2,105 · Balance 0 F1: On February 2, 2026, pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of October 29, 2025, by and among Terex Corporation, a Delaware corporation ("Terex"), Tag Merger Sub 1 Inc. ("Merger Sub 1"), a Delaware corporation and wholly owned subsidiary of Terex, Tag Merger Sub 2 LLC, a Delaware limited liability company and wholly owned subsidiary of Terex ("Merger Sub 2"), and REV Group, Inc. (the "Issuer"), among other things, Merger Sub 1 merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Terex (the "First Merger"). Immediately following the First Merger, Issuer merged with and into Merger Sub 2, with Merger Sub 2 continuing as the surviving corporation and a wholly owned subsidiary of Terex. F3: At the Effective Time, each outstanding restricted stock unit award of the Issuer ("Issuer RSU Award") held by the reporting person as of immediately prior to the Effective Time, whether or not vested, was cancelled and converted into a Terex RSU Award covering a number of shares of Terex Common Stock equal to (i) the number of shares of Issuer Common Stock subject to the Issuer RSU Award as of immediately prior to the Effective Time, multiplied by (ii) 1.1309. The dividend equivalents accrued, but unpaid, with respect to each such Issuer RSU Award were converted to a restricted cash payment ("RSU Restricted Cash Payment"). The resulting Terex RSU Awards and RSU Restricted Cash Payments are each generally subject to the same vesting criteria as the corresponding Issuer RSU Award as of immediately prior to the Effective Time

Filing footnotes · ownership attribution and instrument terms

F1: On February 2, 2026, pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of October 29, 2025, by and among Terex Corporation, a Delaware corporation ("Terex"), Tag Merger Sub 1 Inc. ("Merger Sub 1"), a Delaware corporation and wholly owned subsidiary of Terex, Tag Merger Sub 2 LLC, a Delaware limited liability company and wholly owned subsidiary of Terex ("Merger Sub 2"), and REV Group, Inc. (the "Issuer"), among other things, Merger Sub 1 merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Terex (the "First Merger"). Immediately following the First Merger, Issuer merged with and into Merger Sub 2, with Merger Sub 2 continuing as the surviving corporation and a wholly owned subsidiary of Terex.

F2: At the effective time of the First Merger (the "Effective Time"), each outstanding share of Issuer common stock ("Issuer Common Stock") held by the reporting person as of immediately prior to the Effective Time was cancelled and converted into the right to receive from Terex (i) 0.9809 shares of Terex common stock, par value $0.01 per share ("Terex Common Stock") and (ii) $8.71 in cash without interest.

F3: At the Effective Time, each outstanding restricted stock unit award of the Issuer ("Issuer RSU Award") held by the reporting person as of immediately prior to the Effective Time, whether or not vested, was cancelled and converted into a Terex RSU Award covering a number of shares of Terex Common Stock equal to (i) the number of shares of Issuer Common Stock subject to the Issuer RSU Award as of immediately prior to the Effective Time, multiplied by (ii) 1.1309. The dividend equivalents accrued, but unpaid, with respect to each such Issuer RSU Award were converted to a restricted cash payment ("RSU Restricted Cash Payment"). The resulting Terex RSU Awards and RSU Restricted Cash Payments are each generally subject to the same vesting criteria as the corresponding Issuer RSU Award as of immediately prior to the Effective Time

Sucampo Pharmaceuticals, Inc.

Report date February 13, 2018 · Filed February 13, 2018

Section 16 reporting ended · disclosed 2018-02-13. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common Stock, Class ASEC Table I · non-derivative	Direct	Reported balance After 2018-02-13 transaction · row 1 1 source row Row 1 · 2018-02-13 · Disposition to issuer · Disposed 5,130 · Balance 0 F1: This common stock was purchased for $18.00 per share share in cash, subject to any required withholding of taxes and without interest, upon the effective time of the merger of Sun Acquisition Co.with and into Sucampo Pharmaceuticals, Inc. pursuant to that certain Agreement and Plan of Merger by and among Mallinckrodt plc, Sun Acquisition Co. and Sucampo Pharmaceuticals, Inc. dated December 23, 2017 (the "Merger Agreement"). The common stock consisted of restricted stock units that were accelerated as a result of the Merger Agreement.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.19 · Expires 2023-03-01	Direct	Reported balance After 2018-02-13 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2018-02-13 · Disposition to issuer · Disposed 30,000 · Balance 0 F2: This option was cancelled and converted into the right to receive in cash the amount per share by which $18.00 exceeds the exercise price of the option, subject to any applicable tax witholdings (such amount, the "Option Spread"), upon the effective time of the merger of Sun Acquisition Co.with and into Sucampo Pharmaceuticals, Inc. pursuant to the Merger Agreement. The Option Spread for the unvested portion of the option, if any, will be paid in accordance with the schedule described in the Merger Agreement.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.62 · Expires 2023-05-22	Direct	Reported balance After 2018-02-13 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2018-02-13 · Disposition to issuer · Disposed 20,000 · Balance 0 F2: This option was cancelled and converted into the right to receive in cash the amount per share by which $18.00 exceeds the exercise price of the option, subject to any applicable tax witholdings (such amount, the "Option Spread"), upon the effective time of the merger of Sun Acquisition Co.with and into Sucampo Pharmaceuticals, Inc. pursuant to the Merger Agreement. The Option Spread for the unvested portion of the option, if any, will be paid in accordance with the schedule described in the Merger Agreement.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.80 · Expires 2024-05-09	Direct	Reported balance After 2018-02-13 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2018-02-13 · Disposition to issuer · Disposed 20,000 · Balance 0 F2: This option was cancelled and converted into the right to receive in cash the amount per share by which $18.00 exceeds the exercise price of the option, subject to any applicable tax witholdings (such amount, the "Option Spread"), upon the effective time of the merger of Sun Acquisition Co.with and into Sucampo Pharmaceuticals, Inc. pursuant to the Merger Agreement. The Option Spread for the unvested portion of the option, if any, will be paid in accordance with the schedule described in the Merger Agreement.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.23 · Expires 2025-05-29	Direct	Reported balance After 2018-02-13 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2018-02-13 · Disposition to issuer · Disposed 20,000 · Balance 0 F2: This option was cancelled and converted into the right to receive in cash the amount per share by which $18.00 exceeds the exercise price of the option, subject to any applicable tax witholdings (such amount, the "Option Spread"), upon the effective time of the merger of Sun Acquisition Co.with and into Sucampo Pharmaceuticals, Inc. pursuant to the Merger Agreement. The Option Spread for the unvested portion of the option, if any, will be paid in accordance with the schedule described in the Merger Agreement.
Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.30 · Expires 2027-06-01	Direct	Reported balance After 2018-02-13 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2018-02-13 · Disposition to issuer · Disposed 10,000 · Balance 0 F2: This option was cancelled and converted into the right to receive in cash the amount per share by which $18.00 exceeds the exercise price of the option, subject to any applicable tax witholdings (such amount, the "Option Spread"), upon the effective time of the merger of Sun Acquisition Co.with and into Sucampo Pharmaceuticals, Inc. pursuant to the Merger Agreement. The Option Spread for the unvested portion of the option, if any, will be paid in accordance with the schedule described in the Merger Agreement.

Filing footnotes · ownership attribution and instrument terms

F1: This common stock was purchased for $18.00 per share share in cash, subject to any required withholding of taxes and without interest, upon the effective time of the merger of Sun Acquisition Co.with and into Sucampo Pharmaceuticals, Inc. pursuant to that certain Agreement and Plan of Merger by and among Mallinckrodt plc, Sun Acquisition Co. and Sucampo Pharmaceuticals, Inc. dated December 23, 2017 (the "Merger Agreement"). The common stock consisted of restricted stock units that were accelerated as a result of the Merger Agreement.

F2: This option was cancelled and converted into the right to receive in cash the amount per share by which $18.00 exceeds the exercise price of the option, subject to any applicable tax witholdings (such amount, the "Option Spread"), upon the effective time of the merger of Sun Acquisition Co.with and into Sucampo Pharmaceuticals, Inc. pursuant to the Merger Agreement. The Option Spread for the unvested portion of the option, if any, will be paid in accordance with the schedule described in the Merger Agreement.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
December 20, 2016 Filed Dec 20, 2016 22:26 UTC	SCHOLASTIC CORP SCHL · Entity 5192	SaleCommon Stock	4,521	$48.32	$218,454.72	Disclosure SEC source: 0001179110-16-033317 · edgar.xml · nonDerivative · entry 7 OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,129 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.53, inclusive. The reporting person undertakes to provide to Scholastic Corporation, any holder of Scholastic Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. Read SEC document
December 20, 2016 Filed Dec 21, 2016 22:57 UTC	SCHOLASTIC CORP SCHL · Entity 5192	Exercise / conversionEmployee stock option (right to buy) · Derivative	9,597	$0.00 Strike: $33.87	$0.00	Disclosure SEC source: 0001179110-16-033362 · edgar.xml · derivative · entry 3 OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,194 Underlying: Common Stock · 9,597 shares Expires 2024-09-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Employee stock options vest ratably over a four year period beginning with the first anniversary after the date of grant. Read SEC document
December 20, 2016 Filed Dec 21, 2016 22:57 UTC	SCHOLASTIC CORP SCHL · Entity 5192	SaleCommon Stock	9,597	$48.08	$461,442.95	Disclosure SEC source: 0001179110-16-033362 · edgar.xml · nonDerivative · entry 2 OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,129 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.42, inclusive. The reporting person undertakes to provide to Scholastic Corporation, any holder of Scholastic Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document
December 20, 2016 Filed Dec 21, 2016 22:57 UTC	SCHOLASTIC CORP SCHL · Entity 5192	Exercise / conversionCommon Stock	9,597	$33.87	$325,050.39	Disclosure SEC source: 0001179110-16-033362 · edgar.xml · nonDerivative · entry 1 OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 19, 2016 Filed Dec 20, 2016 22:26 UTC	SCHOLASTIC CORP SCHL · Entity 5192	Exercise / conversionEmployee stock option (right to buy) · Derivative	11,597	$0.00 Strike: $33.87	$0.00	Disclosure SEC source: 0001179110-16-033317 · edgar.xml · derivative · entry 9 OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,791 Underlying: Common Stock · 11,597 shares Expires 2024-09-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Employee stock options vest ratably over a four year period beginning with the first anniversary after the date of grant. Read SEC document
December 19, 2016 Filed Dec 20, 2016 22:26 UTC	SCHOLASTIC CORP SCHL · Entity 5192	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	11,645	$0.00 Strike: $30.17	$0.00	Disclosure SEC source: 0001179110-16-033317 · edgar.xml · derivative · entry 8 OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,645 Underlying: Common Stock · 11,645 shares Expires 2023-09-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Employee stock options vest ratably over a four year period beginning with the first anniversary after the date of grant. Read SEC document
December 19, 2016 Filed Dec 20, 2016 22:26 UTC	SCHOLASTIC CORP SCHL · Entity 5192	SaleCommon Stock	25	$48.00	$1,200.00	Disclosure SEC source: 0001179110-16-033317 · edgar.xml · nonDerivative · entry 6 OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By son, as custodian Disclosed balance after: 40,650 Read SEC document
December 19, 2016 Filed Dec 20, 2016 22:26 UTC	SCHOLASTIC CORP SCHL · Entity 5192	SaleCommon Stock	5,479	$47.97	$262,833.11	Disclosure SEC source: 0001179110-16-033317 · edgar.xml · nonDerivative · entry 5 OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,675 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.95 to $48.00, inclusive. The reporting person undertakes to provide to Scholastic Corporation, any holder of Scholastic Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document
December 19, 2016 Filed Dec 20, 2016 22:26 UTC	SCHOLASTIC CORP SCHL · Entity 5192	SaleCommon Stock	11,597	$48.01	$556,806.76	Disclosure SEC source: 0001179110-16-033317 · edgar.xml · nonDerivative · entry 4 OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,154 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.12, inclusive. The reporting person undertakes to provide to Scholastic Corporation, any holder of Scholastic Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document
December 19, 2016 Filed Dec 20, 2016 22:26 UTC	SCHOLASTIC CORP SCHL · Entity 5192	Exercise / conversionCommon Stock	11,597	$33.87	$392,790.39	Disclosure SEC source: 0001179110-16-033317 · edgar.xml · nonDerivative · entry 3 OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 19, 2016 Filed Dec 20, 2016 22:26 UTC	SCHOLASTIC CORP SCHL · Entity 5192	SaleCommon Stock	11,645	$48.02	$559,204.55	Disclosure SEC source: 0001179110-16-033317 · edgar.xml · nonDerivative · entry 2 OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,154 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.14, inclusive. The reporting person undertakes to provide to Scholastic Corporation, any holder of Scholastic Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document
December 19, 2016 Filed Dec 20, 2016 22:26 UTC	SCHOLASTIC CORP SCHL · Entity 5192	Exercise / conversionCommon Stock	11,645	$30.17	$351,329.65	Disclosure SEC source: 0001179110-16-033317 · edgar.xml · nonDerivative · entry 1 OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
September 23, 2016 Filed Sep 26, 2016 20:31 UTC	SCHOLASTIC CORP SCHL · Entity 5192	Tax withholdingCommon Stock	800	$38.69	$30,952.00	Disclosure SEC source: 0001179110-16-030024 · edgar.xml · nonDerivative · entry 1 OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,154 F1 · shares: Represents shares withheld to cover taxes owed upon the vesting of 1,550 restricted stock units. F1 · price: Represents shares withheld to cover taxes owed upon the vesting of 1,550 restricted stock units. Read SEC document
September 21, 2016 Filed Sep 22, 2016 20:05 UTC	SCHOLASTIC CORP SCHL · Entity 5192	Tax withholdingCommon Stock	622	$38.56	$23,984.32	Disclosure SEC source: 0001179110-16-029926 · edgar.xml · nonDerivative · entry 3 OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,954 F2 · shares: Represents shares withheld to cover taxes owed upon the vesting of 1,205 restricted stock units. F2 · price: Represents shares withheld to cover taxes owed upon the vesting of 1,205 restricted stock units. Read SEC document
September 20, 2016 Filed Sep 22, 2016 20:05 UTC	SCHOLASTIC CORP SCHL · Entity 5192	GrantEmployee stock option (right to buy) · Derivative	39,613	$0.00 Strike: $39.16	$0.00	Disclosure SEC source: 0001179110-16-029926 · edgar.xml · derivative · entry 5 OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,613 Underlying: Common Stock · 39,613 shares Expires 2026-09-20 F3 · derivative.exercise_date: The grant becomes exercisable in four equal annual installments beginning with the first anniversary of the date of grant. Read SEC document
September 20, 2016 Filed Sep 22, 2016 20:05 UTC	SCHOLASTIC CORP SCHL · Entity 5192	GrantCommon Stock	5,362	$39.16	$209,975.92	Disclosure SEC source: 0001179110-16-029926 · edgar.xml · nonDerivative · entry 2 OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,576 Read SEC document
September 20, 2016 Filed Sep 22, 2016 20:05 UTC	SCHOLASTIC CORP SCHL · Entity 5192	Tax withholdingCommon Stock	898	$39.21	$35,210.58	Disclosure SEC source: 0001179110-16-029926 · edgar.xml · nonDerivative · entry 1 OCONNELL MAUREEN · CIK 0001111318 · EVP, CAO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,214 F1 · shares: Represents shares withheld to cover taxes owed upon the vesting of 1,740 restricted stock units. F1 · price: Represents shares withheld to cover taxes owed upon the vesting of 1,740 restricted stock units. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.